Update analytics/transcripts.jsonl

analytics/transcripts.jsonl

@@ -1 +1,2 @@
 {"timestamp_utc": "2025-09-25T19:16:40.067637+00:00", "session_id": "ea2f0fc9-04c3-4865-ba3e-6410239f8bb9", "first_name": "Naz", "last_name": "Nafisi", "question": "what is rigidity analysis ?", "answer": "Answer: Rigidity analysis refers to the measurement of the ability of a material to resist external forces and maintain its shape. In the context of bone, it involves the evaluation of the material properties and geometry of bone tissue to predict its resistance to deformation under load. It is a quantitative method used to assess bone strength and stability, particularly in cases of oseseous neoplasm where the risk of pathological fractures is high. By analyzing the structural properties of the bone, such as cortical thickness, trabeculae spacing, and bone mineral density, rigority analysis provides a more accurate prediction of fractures risks than traditional methods like plain radiography."}
+{"timestamp_utc": "2025-09-25T19:18:33.049648+00:00", "session_id": "ea2f0fc9-04c3-4865-ba3e-6410239f8bb9", "first_name": "Naz", "last_name": "Nafisi", "question": "how can I correlate the omics data with functional data driven from pain analysis in a fracture healing study", "answer": "Answer: To correlate omics (e.g., transcriptomics, proteomics) data with pain analysis, you could consider the following steps: 1. Identify differentially expressed genes (DEGs) or proteins associated with pain using techniques like differential expression analysis (DEA) or machine learning models. 2. Map DEGs/proteins to specific cell types or tissues using single-cell RNA sequencing (scRNA-seq) or spatial transcriptomic data. 3. Analyze their biological functions using pathway enrichment analysis or gene set enrichments. 4. Compare these findings with pain scores or clinical outcomes (either self-reported or objective measures). 5. Validate findings through experimental validation (e g., qPCR, Western blotting, immunohistochemistry). 6. Incorporate pain data into multi-omics analyses, such as integrating transcriptome and proteome data using methods like PCA or PLS-DA. 7. Consider potential therapeutic targets based on identified molecular mechanisms. 8. Repeat this process for other omics datasets (e .g., metabolomics). 9. Interpret results in the context of existing literature and clinical relevance. In the case of UC, you might look for pain-associated changes in bone remodeling markers, cytokines, or immune response-related molecules. However, it's important to note that pain is complex and multifactorial, so correlation alone may not fully explain its underlying mechanisms."}